Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
UCB
Pharma
Syndax strikes $350M funding deal with Royalty Pharma
To help foot the bill for two commercial launches, Syndax Pharmaceuticals has struck a $350 million deal with Royalty Pharma.
Kevin Dunleavy
Nov 5, 2024 10:50am
UCB collects 3 new FDA approvals for blockbuster hopeful Bimzelx
Sep 23, 2024 12:12pm
Sanofi, DualityBio, UCB—Fierce Pharma Asia
Aug 30, 2024 8:05am
UCB strikes $680M divestment deal in China
Aug 26, 2024 9:20am
UCB backs Emmy Award winner's musical about living with epilepsy
Jul 31, 2024 5:49am
Samsung Bio retools $223M production pact with Baxter
Jun 20, 2024 9:36am
